Treatments

Paxlovid does not shorten COVID symptoms among fully vaccinated--study

Fri, 2024-04-05 22:21 — mike kraft

Among fully vaccinated, study shows Paxlovid does not shorten symptoms A new study in the New England Journal of Medicine suggests that, for those fully vaccinated against COVID-19 but having at least one risk factor for severe COVID, the antiviral drug Paxlovid did little to reduce symptom duration, but experts caution the findings might not apply to older patients. CIDRAP

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Paxlovid does not shorten COVID symptoms among fully vaccinated--study
Log in or register to post comments

Misinformation issue: Four years after shelter-in place, COVID misinformation continues

Mon, 2024-04-01 23:49 — mike kraft

Four Years After Shelter-in-Place, Covid-19 Misinformation Persists - KFF Health News False claims that covid vaccines cause deaths and other diseases are still prevalent despite multiple studies showing the vaccines are safe and saved lives. khnkit KFF Health News

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Misinformation issue: Four years after shelter-in place, COVID misinformation continues
Log in or register to post comments

Covid pandemic provided an opportunity to watch the human immune system respond in real time

Fri, 2024-03-29 22:46 — mike kraft

Covid’s scientific silver lining: A chance to watch the human immune system respond in real time Covid wreaked havoc on the world. It also provided an unprecedented look at the human immune system. Helen Branswell STAT

...

The Covid pandemic marked the first time people armed with powerful scientific tools could study how the immune system awakens to and develops defenses against a new threat, in real time, in the global population.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Covid pandemic provided an opportunity to watch the human immune system respond in real time
Log in or register to post comments

U.S. FDA settles lawsuit over its criticisms of using ivermectin to counter COVID

Fri, 2024-03-29 22:14 — mike kraft

...

FDA settles lawsuit over ivermectin content that doctors claimed harmed their practice | CNN The US Food and Drug Administration has settled a lawsuit over some of its posts about ivermectin, including what may have been one of its more popular pandemic-era social media campaigns. Jen Christensen CNN

The FDA said in an email to CNN on Wednesday that it “has chosen to resolve this lawsuit rather than continuing to litigate over statements that are between two and nearly four years old.”

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. FDA settles lawsuit over its criticisms of using ivermectin to counter COVID
Log in or register to post comments

COVID booster cuts severe COVID risk by a third in patients with weak immune systems--study

Fri, 2024-03-29 05:07 — mike kraft

Study: COVID booster cuts severe COVID risk by a third in patients with weak immune systems One dose of the updated, single-strain COVID-19 vaccine introduced last fall is 38% effective against hospitalization in the 7 to 59 days after receipt and 34% effective at 60 to 119 days in adults with weakened immune systems, yet uptake in this group is low, estimates a study published today in Morbidity and Mortality Weekly Report. CIDRAP

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about COVID booster cuts severe COVID risk by a third in patients with weak immune systems--study
Log in or register to post comments

U.S. FDA approves COVID preventive Pemgarda for immunocompromised persons

Tue, 2024-03-26 22:08 — mike kraft

FDA OKs Invivyd's COVID preventive Pemgarda for emergency use The pre-exposure treatment is indicated for adolescents and adults with moderate-to-severe immunocompromising conditions. CIDRAP

The Food and Drug Administration (FDA) on March 22 granted emergency use authorization (EUA) for Invivyd's monoclonal antibody to prevent COVID-19 in immunocompromised patients, which fills a gap following the withdrawal of Evusheld in January 2023.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. FDA approves COVID preventive Pemgarda for immunocompromised persons
Log in or register to post comments

Paxlovid outperforms molnupiravir against severe COVID-19 outcomes --study

Mon, 2024-03-25 22:16 — mike kraft

New data show Paxlovid outperforms molnupiravir against severe COVID-19 outcomes A large study yesterday in the International Journal of Infectious Diseases shows that, if prescribed within 5 days of confirmed infection, Paxlovid (nirmatrelvir-ritonavir) is more effective in protecting against all-cause mortality and severe COVID-19 in adults than is molnupiravir, another antiviral drug. CIDRAP

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Paxlovid outperforms molnupiravir against severe COVID-19 outcomes --study
Log in or register to post comments

COVID vaccines cut post infection risk of heart failure and blood clots--study

Thu, 2024-03-21 21:53 — mike kraft

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about COVID vaccines cut post infection risk of heart failure and blood clots--study
Log in or register to post comments

After 4 years of COVID, experts are just beginning to understand long COVID

Wed, 2024-03-20 23:10 — mike kraft

4 years later, experts are just beginning to 'scratch the surface' of understanding long COVID Four years after the WHO declared the COVID-19 outbreak to be a pandemic, researchers say much is still not understood about a common complication: long COVID. ABC News ABC News

...

Since the early days of the pandemic, scientists have learned a great deal about what puts someone at risk for long COVID, but researchers say we are still "scratching the surface" when it comes to our understanding of what causes the condition or how to treat it.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about After 4 years of COVID, experts are just beginning to understand long COVID
Log in or register to post comments

Marking the fading of the COVID pandemic, the U.S. NIH is shelving its COVID treatment guidelines

Wed, 2024-03-20 22:16 — mike kraft

In a pandemic milestone, the NIH ends guidance on COVID treatment The National Institutes of Health is sunsetting its influential COVID-19 treatment guidelines, used by millions of doctors to guide care during the pandemic. NPR

...

The last version of the NIH's COVID-19 Treatment Guidelines was issued in February. The archives of the guidance — available online until August — document how scientific understanding and technological progress evolved during the pandemic.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?: